Study ID: BDB-AS-101
Study Title
- A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults
Teva Identifier
- BDB-AS-101
ClinicalTrials.gov Identifier
- NCT02030457
Study Status
- Completed
Trial Condition(s)
- Pharmacokinetics
Interventions
- Drug: Beclomethasone dipropionate BAI | Drug: Beclomethasone dipropionate MDI
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 45 Years
Trial Duration
- 12/01/2013 - 06/01/2014
Phase
- Phase 1
Study Type
Interventional